Prolactin is a peripheral marker of manganese neurotoxicity

A. P. Marreilha Dos Santos, M. Lopes Santos, Maria C. Batoréu, Michael Aschner

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Excessive exposure to Mn induces neurotoxicity, referred to as manganism. Exposure assessment relies on Mn blood and urine analyses, both of which show poor correlation to exposure. Accordingly, there is a critical need for better surrogate biomarkers of Mn exposure. The aim of this study was to examine the relationship between Mn exposure and early indicators of neurotoxicity, with particular emphasis on peripheral biomarkers. Male Wistar rats (180-200 g) were injected intraperitoneally with 4 or 8 doses of Mn (10 mg/kg). Mn exposure was evaluated by analysis of Mn levels in brain and blood along with biochemical end-points (see below). Results: Brain Mn levels were significantly increased both after 4 and 8 doses of Mn compared with controls (p < 0.001). Blood levels failed to reflect a dose-dependent increase in brain Mn, with only the 8-dose-treated group showing significant differences (p < 0.001). Brain glutathione (GSH) levels were significantly decreased in the 8-dose-treated animals (p < 0.001). A significant and dose-dependent increase in prolactin levels was found for both treated groups (p < 0.001) compared to controls. In addition, a decrease in motor activity was observed in the 8-dose-treated group compared to controls. Conclusions: (1) The present study demonstrates that peripheral blood level is a poor indicator of Mn brain accumulation and exposure; (2) Mn reduces GSH brain levels, likely reflecting oxidative stress; (3) Mn increases blood prolactin levels, indicating changes in the integrity of the dopaminergic system. Taken together these results suggest that peripheral prolactin levels may serve as reliable predictive biomarkers of Mn neurotoxicity.

Original languageEnglish (US)
Pages (from-to)282-290
Number of pages9
JournalBrain Research
Volume1382
DOIs
StatePublished - Mar 25 2011
Externally publishedYes

Fingerprint

Manganese
Prolactin
Brain
Biomarkers
Glutathione
Wistar Rats
Motor Activity
Oxidative Stress
Urine

Keywords

  • Behavior
  • Biomarkers
  • Manganese
  • Neurotoxicity
  • Prolactin

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Marreilha Dos Santos, A. P., Lopes Santos, M., Batoréu, M. C., & Aschner, M. (2011). Prolactin is a peripheral marker of manganese neurotoxicity. Brain Research, 1382, 282-290. https://doi.org/10.1016/j.brainres.2011.01.047

Prolactin is a peripheral marker of manganese neurotoxicity. / Marreilha Dos Santos, A. P.; Lopes Santos, M.; Batoréu, Maria C.; Aschner, Michael.

In: Brain Research, Vol. 1382, 25.03.2011, p. 282-290.

Research output: Contribution to journalArticle

Marreilha Dos Santos, AP, Lopes Santos, M, Batoréu, MC & Aschner, M 2011, 'Prolactin is a peripheral marker of manganese neurotoxicity', Brain Research, vol. 1382, pp. 282-290. https://doi.org/10.1016/j.brainres.2011.01.047
Marreilha Dos Santos, A. P. ; Lopes Santos, M. ; Batoréu, Maria C. ; Aschner, Michael. / Prolactin is a peripheral marker of manganese neurotoxicity. In: Brain Research. 2011 ; Vol. 1382. pp. 282-290.
@article{436e90b52e5a4c7fa112f9c93c073699,
title = "Prolactin is a peripheral marker of manganese neurotoxicity",
abstract = "Excessive exposure to Mn induces neurotoxicity, referred to as manganism. Exposure assessment relies on Mn blood and urine analyses, both of which show poor correlation to exposure. Accordingly, there is a critical need for better surrogate biomarkers of Mn exposure. The aim of this study was to examine the relationship between Mn exposure and early indicators of neurotoxicity, with particular emphasis on peripheral biomarkers. Male Wistar rats (180-200 g) were injected intraperitoneally with 4 or 8 doses of Mn (10 mg/kg). Mn exposure was evaluated by analysis of Mn levels in brain and blood along with biochemical end-points (see below). Results: Brain Mn levels were significantly increased both after 4 and 8 doses of Mn compared with controls (p < 0.001). Blood levels failed to reflect a dose-dependent increase in brain Mn, with only the 8-dose-treated group showing significant differences (p < 0.001). Brain glutathione (GSH) levels were significantly decreased in the 8-dose-treated animals (p < 0.001). A significant and dose-dependent increase in prolactin levels was found for both treated groups (p < 0.001) compared to controls. In addition, a decrease in motor activity was observed in the 8-dose-treated group compared to controls. Conclusions: (1) The present study demonstrates that peripheral blood level is a poor indicator of Mn brain accumulation and exposure; (2) Mn reduces GSH brain levels, likely reflecting oxidative stress; (3) Mn increases blood prolactin levels, indicating changes in the integrity of the dopaminergic system. Taken together these results suggest that peripheral prolactin levels may serve as reliable predictive biomarkers of Mn neurotoxicity.",
keywords = "Behavior, Biomarkers, Manganese, Neurotoxicity, Prolactin",
author = "{Marreilha Dos Santos}, {A. P.} and {Lopes Santos}, M. and Bator{\'e}u, {Maria C.} and Michael Aschner",
year = "2011",
month = "3",
day = "25",
doi = "10.1016/j.brainres.2011.01.047",
language = "English (US)",
volume = "1382",
pages = "282--290",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Prolactin is a peripheral marker of manganese neurotoxicity

AU - Marreilha Dos Santos, A. P.

AU - Lopes Santos, M.

AU - Batoréu, Maria C.

AU - Aschner, Michael

PY - 2011/3/25

Y1 - 2011/3/25

N2 - Excessive exposure to Mn induces neurotoxicity, referred to as manganism. Exposure assessment relies on Mn blood and urine analyses, both of which show poor correlation to exposure. Accordingly, there is a critical need for better surrogate biomarkers of Mn exposure. The aim of this study was to examine the relationship between Mn exposure and early indicators of neurotoxicity, with particular emphasis on peripheral biomarkers. Male Wistar rats (180-200 g) were injected intraperitoneally with 4 or 8 doses of Mn (10 mg/kg). Mn exposure was evaluated by analysis of Mn levels in brain and blood along with biochemical end-points (see below). Results: Brain Mn levels were significantly increased both after 4 and 8 doses of Mn compared with controls (p < 0.001). Blood levels failed to reflect a dose-dependent increase in brain Mn, with only the 8-dose-treated group showing significant differences (p < 0.001). Brain glutathione (GSH) levels were significantly decreased in the 8-dose-treated animals (p < 0.001). A significant and dose-dependent increase in prolactin levels was found for both treated groups (p < 0.001) compared to controls. In addition, a decrease in motor activity was observed in the 8-dose-treated group compared to controls. Conclusions: (1) The present study demonstrates that peripheral blood level is a poor indicator of Mn brain accumulation and exposure; (2) Mn reduces GSH brain levels, likely reflecting oxidative stress; (3) Mn increases blood prolactin levels, indicating changes in the integrity of the dopaminergic system. Taken together these results suggest that peripheral prolactin levels may serve as reliable predictive biomarkers of Mn neurotoxicity.

AB - Excessive exposure to Mn induces neurotoxicity, referred to as manganism. Exposure assessment relies on Mn blood and urine analyses, both of which show poor correlation to exposure. Accordingly, there is a critical need for better surrogate biomarkers of Mn exposure. The aim of this study was to examine the relationship between Mn exposure and early indicators of neurotoxicity, with particular emphasis on peripheral biomarkers. Male Wistar rats (180-200 g) were injected intraperitoneally with 4 or 8 doses of Mn (10 mg/kg). Mn exposure was evaluated by analysis of Mn levels in brain and blood along with biochemical end-points (see below). Results: Brain Mn levels were significantly increased both after 4 and 8 doses of Mn compared with controls (p < 0.001). Blood levels failed to reflect a dose-dependent increase in brain Mn, with only the 8-dose-treated group showing significant differences (p < 0.001). Brain glutathione (GSH) levels were significantly decreased in the 8-dose-treated animals (p < 0.001). A significant and dose-dependent increase in prolactin levels was found for both treated groups (p < 0.001) compared to controls. In addition, a decrease in motor activity was observed in the 8-dose-treated group compared to controls. Conclusions: (1) The present study demonstrates that peripheral blood level is a poor indicator of Mn brain accumulation and exposure; (2) Mn reduces GSH brain levels, likely reflecting oxidative stress; (3) Mn increases blood prolactin levels, indicating changes in the integrity of the dopaminergic system. Taken together these results suggest that peripheral prolactin levels may serve as reliable predictive biomarkers of Mn neurotoxicity.

KW - Behavior

KW - Biomarkers

KW - Manganese

KW - Neurotoxicity

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=79952536116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952536116&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2011.01.047

DO - 10.1016/j.brainres.2011.01.047

M3 - Article

VL - 1382

SP - 282

EP - 290

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -